
Urs Kunz
analystMale0.0Global Dominance: 0.00%
Urs Kunz is a healthcare analyst with Research Partners, a Swiss equity research provider. He specializes in analyzing the pharmaceutical and healthcare sectors, providing insights on market dynamics and company performance. Recently, he commented on the competitive landscape between DocMorris and Redcare, highlighting the challenges faced by DocMorris in scaling its business and the impact of marketing investments on revenue growth.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Urs Kunz, a healthcare analyst, suggests that DocMorris's financial difficulties are a key reason for its stagnant business despite favorable conditions.
Warum DocMorris weiterhin hinter Redcare zurückbleibtNeue Zürcher Zeitung·
Switzerland· 2025-10-05

